Özge Arıcı Düz

Özge Arıcı Düz

Auto-generated profile, based on publicly available information

Özge Arıcı Düz

Istanbul Medipol University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2018 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
BYBurak Yulug
Burak Yulug
LHLutfu Hanoglu
Lutfu Hanoglu
EKElmir Khanmammadov
Elmir Khanmammadov
ODOzge Arici Duz
Ozge Arici Duz
BPBurcu Polat
Burcu Polat
EKErtugrul Kilic
Ertugrul Kilic
There are limited studies in the literature evaluating region specific neuroprotective effects of repetitive transcranial magnetic stimulation (rTMS) in Alzheimer’s Disease. Here, we aimed to review the neurochemical correlates of the hippocampal neuroprotective effect of rTMS in various preclinical and clinical studies. Our findings indicate that rTMS may exert a significant neuroprotective effect through acting on the hippocampal Brain Derived Growth Factor (BDNF) levels which may, in turn, slow the progression of Alzheimer’s Disease. Clarifying the neuroprotective correlates of hippocampus oriented rTMS protocols may open novel avenues for Alzheimer’s Disease (AD) treatment.

7 March 2019 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
ODOzge Arici Duz
Ozge Arici Duz
NYNesrin Helvaci Yilmaz
Nesrin Helvaci Yilmaz

15 January 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
AAAytug Altundag
Aytug Altundag
OSOzlem Saatci
Ozlem Saatci
SKSedat G. Kandemirli
Sedat G. Kandemirli
DSDeniz Esin Tekcan Sanli
Deniz Esin Tekcan Sanli
ODOzge A. Duz
Ozge A. Duz
DYDuzgun Yildirim
Duzgun Yildirim

8 April 2021 in European Neurology
Verified
Journal Article
Closed access
PDF file
ODOzge Arici Duz
Ozge Arici Duz
OSOzlem Saatci
Ozlem Saatci
EKEce Zeynep Karakulak
Ece Zeynep Karakulak
EBErkingul Birday
Erkingul Birday
LHLutfu Hanoglu
Lutfu Hanoglu
Background: Multiple Sclerosis (MS) is a neuroinflammatory, neurodegenerative, demyelinating disease that causes cognitive, olfactory, and other neurological dysfunctions. Radiologically Isolated Syndrome (RIS), in which only radiological findings are monitored, is accepted as the preclinical stage of demyelinating disease and is considered an important period for disease pathology. Therefore, in this study, we aimed to evaluate the olfactory and cognitive functions and their clinical correlation in RIS and Relapsing-Remitting MS (RRMS) patients and a healthy control group. Methods: Our study included 10 RRMS patients, 10 RIS patients, and 10 healthy controls. We conducted an olfactor evaluation via the “Sniffin’ Sticks” test. The subjects underwent a neuropsychometric test battery to evaluate cognitive functions, including memory, visuospatial, and executive functions. Depression was evaluated using the Beck depression scale. Fatigue and daily life activity were evaluated using the Fatigue Severity Scale (FSS) and the 36-Item Short Form Survey (SF-36), respectively. Disability assessment was done with the Expanded Disability Status Scale (EDSS). Results: RRMS and RIS patients’ olfactory test scores were significantly different from those in the control group (p < 0.05). There was a significant difference between the odor threshold scores of patients in the RRMS and RIS groups. There was a significant correlation between memory-oriented cognitive tests and olfactory tests in the RRMS and RIS groups. Conclusion: Olfactory dysfunction can be seen in RIS patients, like in RRMS patients. Cognitive and olfactory dysfunction may be together a sign of degeneration in demyelinating diseases.


1 November 2019 in Aerospace Medicine and Human Performance
Verified
Journal Article
Closed access
ODOzge Arici Düz
Ozge Arici Düz
NYNesrin Helvaci Yilmaz
Nesrin Helvaci Yilmaz
OOOktay Olmuscelik
Oktay Olmuscelik
INTRODUCTION: Restless legs syndrome (RLS) is characterized by an uncomfortable sensation on the legs, which causes the urge to move the legs. The main cause is unknown but there are many risk factors, including geographical properties and high altitude. Our objective was to explore the frequency of RLS in aircrew.METHODS: There were 301 Turkish aircrew who were admitted to Istanbul Medipol University Hospital Neurology Department for periodic examinations and 272 healthy (non-aircrew) subjects included in the study. The International RLS Study Group's Questionnaire and the International RLS Study Group Rating Scale (IRLSSGRS) were used to evaluate RLS. The participants filled the RLS questionnaire and then both groups were divided into two subgroups as having RLS or not. The subjects years in the profession, average flight duration in a month, daily sleep duration, smoking, and coffee consumption were recorded. None of the subjects had previously been diagnosed with RLS.RESULTS: The frequency of RLS was 6.7% in the aircrew group and 7.9% in the control group, and there was no significant difference between the two groups. Age, gender, daily duration of sleep, smoking, coffee consumption, family history of RLS, being a pilot or a flight attendant, years in profession, and monthly flight hours were similar in aircrew with and without RLS.DISCUSSION: The RLS frequency in aircrew was similar to that of the control group. We can conclude flying at high altitude wasnt a risk factor for RLS.Düz OA, Yilmaz NH, Olmuscelik O. Restless legs syndrome in aircrew. Aerosp Med Hum Perform. 2019; 90(11):934937.